Immuno-oncology drug development forges on despite COVID-19
- PMID: 32948858
- DOI: 10.1038/d41573-020-00166-1
Immuno-oncology drug development forges on despite COVID-19
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
